Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors.
Peccatori J, Forcina A, Clerici D, Crocchiolo R, Vago L, Stanghellini MT, Noviello M, Messina C, Crotta A, Assanelli A, Marktel S, Olek S, Mastaglio S, Giglio F, Crucitti L, Lorusso A, Guggiari E, Lunghi F, Carrabba M, Tassara M, Battaglia M, Ferraro A, Carbone MR, Oliveira G, Roncarolo MG, Rossini S, Bernardi M, Corti C, Marcatti M, Patriarca F, Zecca M, Locatelli F, Bordignon C, Fleischhauer K, Bondanza A, Bonini C, Ciceri F. Peccatori J, et al. Among authors: bonini c. Leukemia. 2015 Feb;29(2):396-405. doi: 10.1038/leu.2014.180. Epub 2014 Jun 4. Leukemia. 2015. PMID: 24897508 Clinical Trial.
Progress and prospects: graft-versus-host disease.
Mastaglio S, Stanghellini MT, Bordignon C, Bondanza A, Ciceri F, Bonini C. Mastaglio S, et al. Among authors: bonini c. Gene Ther. 2010 Nov;17(11):1309-17. doi: 10.1038/gt.2010.83. Epub 2010 May 27. Gene Ther. 2010. PMID: 20508597 Review.
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation.
Crucitti L, Crocchiolo R, Toffalori C, Mazzi B, Greco R, Signori A, Sizzano F, Chiesa L, Zino E, Lupo Stanghellini MT, Assanelli A, Carrabba MG, Marktel S, Marcatti M, Bordignon C, Corti C, Bernardi M, Peccatori J, Bonini C, Fleischhauer K, Ciceri F, Vago L. Crucitti L, et al. Among authors: bonini c. Leukemia. 2015 May;29(5):1143-52. doi: 10.1038/leu.2014.314. Epub 2014 Nov 5. Leukemia. 2015. PMID: 25371177
Haploidentical HSCT: a 15-year experience at San Raffaele.
Bonini C, Peccatori J, Stanghellini MT, Vago L, Bondanza A, Cieri N, Greco R, Bernardi M, Corti C, Oliveira G, Zappone E, Traversari C, Bordignon C, Ciceri F. Bonini C, et al. Bone Marrow Transplant. 2015 Jun;50 Suppl 2:S67-71. doi: 10.1038/bmt.2015.99. Bone Marrow Transplant. 2015. PMID: 26039212 Clinical Trial.
Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donors.
Mazzi B, Clerici TD, Zanussi M, Lupo Stanghellini MT, Vago L, Sironi E, Peccatori J, Bernardi M, Carrera P, Palini A, Rossini S, Bordignon C, Bonini C, Ferrari M, Ciceri F, Fleischhauer K. Mazzi B, et al. Among authors: bonini c. Leukemia. 2008 Nov;22(11):2119-22. doi: 10.1038/leu.2008.98. Epub 2008 May 1. Leukemia. 2008. PMID: 18449202 No abstract available.
233 results